Approach to the Triple Negative Breast Cancer in New Drugs Area

Triple negative breast cancers (TNBCs) are associated with aggressive course, higher rates of visceral and central nervous system metastases and lower survival rate than hormone receptor positive. Once metastasis has occurred, a median survival was approximately one year. Currently, chemotherapy in...

Full description

Bibliographic Details
Main Author: Mehrzad Mirzania
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2016-04-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/555